Table 1.
The basic clinical characteristics of HCC patients with CC (n = 35) and TT (n = 16) genotype
| Variables | CC n (%) | TT n (%) | P |
|---|---|---|---|
| Age (year) | 0.091 | ||
| ≤ 50 | 13 (37.14) | 10 (62.50) | |
| > 50 | 22 (62.86) | 6 (37.50) | |
| Gender | 0.370 | ||
| Man | 31 (88.57) | 13 (81.25) | |
| Female | 4 (11.43) | 3 (18.75) | |
| PLT (× 109/L) | 0.022 | ||
| < 180 | 23 (65.71) | 5 (37.50) | |
| ≥ 180 | 12 (34.29) | 11 (62.50) | |
| ALT (U/L) | 0.360 | ||
| ≤ 40 | 23 (65.71) | 8 (50.00 | |
| > 40 | 12 (34.29) | 8 (50.00) | |
| AST (U/L) | 0.179 | ||
| ≤ 40 | 18 (51.43) | 5 (31.25) | |
| > 40 | 17 (48.57) | 11 (68.75) | |
| Albumin/globulin | 0.020 | ||
| ≤ 1.5 | 21 (60.00) | 4 (33.33) | |
| > 1.5 | 14 (40.00) | 12 (66.67) | |
| ALB (g/L) | 0.355 | ||
| ≤ 70 | 18 (51.43) | 6 (37.50) | |
| > 70 | 17 (48.57) | 10 (62.50) | |
| TBIL (μmol/L) | 0.009 | ||
| ≤ 17 | 20 (57.14) | 15 (93.75) | |
| > 17 | 15 (42.86) | 1 (6.67) | |
| DBIL (μmol/L) | 0.043 | ||
| ≤ 7 | 18 (51.43) | 13 (81.25) | |
| > 7 | 17 (48.57) | 3 (18.75) | |
| ALP (U/L) | 0.242 | ||
| ≤ 130 | 27 (77.14) | 15 (93.75) | |
| > 130 | 8 (22.86) | 1 (6.67) | |
| AFP (ng/mL) | 0.246 | ||
| ≤ 300 | 17 (48.57) | 5 (31.25) | |
| > 300 | 18 (51.43) | 11 (68.75) | |
| PT (s) | 0.043 | ||
| ≤ 14 | 26 (74.29) | 16 (100.00) | |
| > 14 | 9 (25.71) | 0 (0) |
P values were calculated from two‐side chi‐square test
AFP: alpha-fetoprotein; ALB: albumin; ALT: alanine amino transferase; ALP: alkaline phosphatase; AST: Aspartate amino transferase; DBIL: direct bilirubin; PLT: platelet; PT: prothrombin time; TBIL: total bilirubin